Dr. Martens (CHIX:DOCSL) EPS (Diluted): £0.02 (TTM As of Mar. 2026)


CHIX:DOCSL Dr. Martens PLC CHIX:DOCSL
52 GF Score
Price £0.70
GF Value £0.72
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Dr. Martens EPS (Diluted)?

Dr. Martens CHIX:DOCSL +1.30% 52 EPS (Diluted) is £0.02 as of Mar. 2026. GuruFocus rates CHIX:DOCSL with a GF Score™ of 52/100 and a GF Value™ of £0.72 (Fairly Valued). The stock has 3 warning signs investors should review.

Dr. Martens's Earnings per Share (Diluted) for the six months ended in Mar. 2026 was £0.03. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was £0.02.

Dr. Martens's EPS (Basic) for the six months ended in Mar. 2026 was £0.04. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was £0.03.

Dr. Martens's EPS without NRI for the six months ended in Mar. 2026 was £0.05. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was £0.04.

During the past 12 months, Dr. Martens's average EPS without NRIGrowth Rate was 70.80% per year. During the past 3 years, the average EPS without NRIGrowth Rate was -31.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was -28.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 9 years, Dr. Martens's highest 3-Year average EPS without NRI Growth Rate was 117.10% per year. The lowest was -48.30% per year. And the median was -14.10% per year.

Dr. Martens  (CHIX:DOCSl) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Dr. Martens EPS (Diluted) Related Terms

Dr. Martens EPS (Diluted) Historical Data

* Premium members only.

The historical data trend for Dr. Martens's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr. Martens EPS (Diluted) Chart

Dr. Martens Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only 0.18 0.13 0.07 0.01 0.02

Dr. Martens Semi-Annual Data
Mar18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 -0.02 0.03 -0.01 0.03

CHIX:DOCSL vs NKE, DECK, ONON: EPS (Diluted) Comparison

For the Footwear & Accessories subindustry, Dr. Martens's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dr. Martens PE Ratio vs Manufacturing - Apparel & Accessories Industry

For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Dr. Martens's PE Ratio distribution charts can be found below:

* The bar in red indicates where Dr. Martens's PE Ratio falls into.


CHIX:DOCSL
52GF Score
Dr. Martens PLC CHIX:DOCSL
EPS (Diluted) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr. Martens EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Dr. Martens's Diluted EPS for the fiscal year that ended in Mar. 2026 is calculated as

Diluted EPS (A: Mar. 2026 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(23.8-0)/979.600
=0.02

Dr. Martens's Diluted EPS for the quarter that ended in Mar. 2026 is calculated as

Diluted EPS (Q: Mar. 2026 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(33.8-0)/959.200
=0.04

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Diluted) →
What does a EPS (Diluted) of £0.02 mean?
Dr. Martens (CHIX:DOCSL) has a EPS (Diluted) of £0.02 as of Mar. 2026. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Dr. Martens and its competitors.
Is Dr. Martens' EPS (Diluted) too high?
Dr. Martens' current EPS (Diluted) is £0.02. Overall, Dr. Martens has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr. Martens' EPS (Diluted) compare to NKE and DECK?
Dr. Martens' EPS (Diluted) of £0.02 can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Manufacturing - Apparel & Accessories company?
A good EPS (Diluted) depends on the Manufacturing - Apparel & Accessories industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Dr. Martens and its competitors. Dr. Martens's current EPS (Diluted) is £0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Martens stock overvalued right now?
Based on GuruFocus' analysis, Dr. Martens (CHIX:DOCSL) is currently considered Fairly Valued. The stock's GF Value™ is £0.72, compared to a current price of £0.70 — trading 2.5% below its estimated fair value. The current EPS (Diluted) is £0.02. Dr. Martens' overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Dr. Martens (CHIX:DOCSL), the current EPS (Diluted) is £0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr. Martens (CHIX:DOCSL) Overvalued in 2026?

Based on GuruFocus' analysis, Dr. Martens stock appears to be undervalued. The current stock price of £0.70 is trading 2.5% below its estimated GF Value™ of £0.72. GuruFocus considers Dr. Martens to be Fairly Valued.

Key valuation signals for CHIX:DOCSL:

  • EPS (Diluted): £0.02
  • GF Value™: £0.72 vs. price of £0.70 (2.5% below fair value)
  • GF Score™: 52/100 with 3 warning signs

No single metric tells the full story. See the CHIX:DOCSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dr. Martens Business Description

Address 28 Jamestown Road, Camden, London, GBR, NW1 7BY
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
52GF Score

Get the complete analysis for CHIX:DOCSL

EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.70
Price
£0.72
GF Value